SMTL ID : 7wky.3 (2 other biounits)

Crystal Structure of the first bromodomain of human BRD4 in complex with the inhibitor Y13153

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.83 Å

Oligo State

monomer

Ligands

1 x JFR: 2-(2-cyclopentyl-1~{H}-imidazol-5-yl)-7-[2-(4-fluoranyl-2,6-dimethyl-phenoxy)-5-(2-oxidanylpropan-2-yl)phenyl]-5-methyl-furo[3,2-c]pyridin-4-one(Non-covalent)

JFR.1: 13 residues within 4Å: Chain A: W.54, P.55, F.56, Q.58, P.59, V.60, D.61, L.65, L.67, N.113, I.119, M.122 Ligands: GOL.2 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:W.54, A:W.54, A:P.55, A:D.61, A:L.65, A:L.65 Hydrogen bonds: A:D.61, A:N.113, A:N.113

1 x GOL: GLYCEROL(Non-functional Binders)

GOL.2: 4 residues within 4Å: Chain A: D.117, D.118, I.119 Ligands: JFR.1 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:I.119

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Li, J. et al., Structure-Based Discovery and Optimization of Furo[3,2- c ]pyridin-4(5 H )-one Derivatives as Potent and Second Bromodomain (BD2)-Selective Bromo and Extra Terminal Domain (BET) Inhibitors. J.Med.Chem. (2022)

Release Date

2022-08-10

Peptides

Bromodomain-containing protein 4: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
C

Bromodomain-containing protein 4

Related Entries With Identical Sequence